ClearPoint Neuro (CLPT) Free Cash Flow (2011 - 2026)

ClearPoint Neuro has disclosed Free Cash Flow across 15 years of filings, most recently posting -$8.6 million for Q1 2026.

• Free Cash Flow for Q1 2026 came in at -$8.6 million, down 35.52% year-over-year; the trailing twelve-month figure through Mar 2026 was -$26.7 million (down 127.25% YoY), and the FY2025 annual result was -$24.4 million, down 164.74% from the prior year.
• Free Cash Flow came in at -$8.6 million for Q1 2026 at ClearPoint Neuro, up from -$12.1 million in the prior quarter.
• In the past five years, Free Cash Flow ranged from a high of -$1.2 million in Q4 2023 to a low of -$12.1 million in Q4 2025.
• The 5-year median for Free Cash Flow is -$3.8 million (2024), against an average of -$4.3 million.
• Across the five-year window, Free Cash Flow soared 61.66% in 2023 and plunged 703.72% in 2025, its largest moves.
• ClearPoint Neuro's Free Cash Flow stood at -$3.1 million in 2022, then jumped by 61.66% to -$1.2 million in 2023, then decreased by 26.55% to -$1.5 million in 2024, then slumped by 703.72% to -$12.1 million in 2025, then increased by 28.85% to -$8.6 million in 2026.
• The last three Free Cash Flow figures came in at -$8.6 million (Q1 2026), -$12.1 million (Q4 2025), and -$3.3 million (Q3 2025), per Business Quant data.